Brazil - Brazzil Mag - Brazil to Break AIDS Drugs Patents in 4 Months
Advertisement
  Home arrow Back Issues arrow 2004 arrow August 2004 arrow Brazil to Break AIDS Drugs Patents in 4 Months Sunday, 12 October 2008 
Main Menu
Home
News
Back Issues
Advertising
Contact Us
Brazil Forum
Magazine
Brazzil Classic
Yellow Pages
Classifieds
Images
BrazzilMag Newsfeed
Custom Search
Amazon Body Care


Personal Loans | Compare | Loans | Mortgage Loans | Loans
-------------
Brazil /Organic personal skin care wholesale / Brazil
--------------
Who's Online
We have 33 guests online
Latest News
Statistics
Members: 405
News: 10022
Web Links: 0
User Menu
Your Details
Submit News
Check-In My Items
My Comments
Login Form





Lost Password?
No account yet? Register
Related Items
Contribution
Have you got news?

Do you have news, comment or story on Brazil you want to share with Brazzil? Just send it our way to brazzil@brazzil.com.

 

Brazil to Break AIDS Drugs Patents in 4 Months PDF Print E-mail
Written by Aline Beckestein   
Monday, 11 April 2005

In 2006, Brazil will begin to produce substances such as AZT, D4T, and 3TC, ingredients which go into the preparation of medicines used to treat HIV/AIDS and which are not protected by patents.

According to the director of the Ministry of Health's STD/AIDS program, Pedro Chequer, Brazil is currently obliged to import these ingredients from countries like India and China. The International Patent Compliance Agreement was signed in 1997 and protects medications.

"The policy that is now in force is for Brazil to produce its own inputs and thus not depend upon importation, which leaves the country vulnerable to market fluctuations and international crises. This alters our prospects by making the country self-sufficient in the production of inputs as well," he affirms.

Chequer also said that the country is already capable of producing the ingredients for some non-patented drugs.

Within a period of 4 months, he said, Brazil will also be able to produce the ingredients for the three medications for which the Ministry requested voluntary licensing (Tenofovir, Efavirenz, and Lopinavir/Ritonavir).

According to Chequer, all companies, state enterprises or not, are eligible to become producers of these substances.

On March 14 the Ministry requested voluntary licensing (equivalent to technology transfer compensated by royalty payments) in a letter addressed to three American pharmaceutical laboratories: Merck Sharp & Dohme, Abbot, and Gilead Science Incorporated. The Ministry expected the laboratories to reply by last Friday (8).

Agência Brasil

Hits: 6159
Comments (1)Add Comment
From Daniel Koffi....
written by Guest, October 03, 2005
Dear Sir,


Our company, JOELLINK INT'L CO;LTD is a sourcing agents based in
Lome-Togo, west Africa.

We got your name through web directory as one of the
supplier/manufacturers
of drugs and are capable to handle the supply of the above product in
large
quantities.

Presently, we have been mandated by the Contract Tender Board of West
African Refugees Agency to source for them a capable and reliable
overseas
company who can effectively undertake to supply drugs, for distribution
to
their different refugees camps in the sub west African countries.

Hence, we want to know your interest and readiness to handle this
project,
as to enable us give you the contract details, for the ongoing tender.

We are looking forward to hearing from you soonest possible.


Best regards

Dan Koffi.
report abuse
vote down
vote up
Votes: +0

Write comment
quote
bold
italicize
underline
strike
url
image
quote
quote
smile
wink
laugh
grin
angry
sad
shocked
cool
tongue
kiss
cry
smaller | bigger

security code
Write the displayed characters


busy




Reddit!Del.icio.us!Facebook!Slashdot!Netscape!Technorati!StumbleUpon!Newsvine!Furl!Yahoo!Ma.gnolia!Add this social bookmarking functionality to your website! title=
 
< Prev   Next >